Table 2 Association of yoga-treatment versus non-yoga treatment with ADA cut-offs and Logistic regression at follow-up.
Outcome | Baseline | Follow up | Logistic Regression analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|
Yoga, n (%) | Non-Yoga, n (%) | P Value | Yoga, n (%) | Non-Yoga, n (%) | P Value | Adjusted OR | Adjusted CI | P Value | |
A1c target | |||||||||
<7% | 34(46.58) | 32(43.84) | 0.868 | 40(54.79) | 27(36.99) | 0.046 | 2.44 | 1.19–5.00 | 0.015 |
≥7% | 39(53.42) | 41(56.16) | 33(45.21) | 46(63.01) | 1(ref) | ||||
BP1 | |||||||||
<130/80 mm Hg | 16(21.92) | 11(15.07) | 0.286 | 25(34.25) | 6 (8.22) | <0.0001 | 6.37 | 2.24–18.08 | 0.001 |
≥ 130/80 mm Hg | 57(78.08) | 62(84.93) | 48(65.75) | 67(91.78) | 1(ref) | ||||
BP2 | |||||||||
<140/90 mmHg | 44 (60.27) | 33(45.21) | 0.097 | 62(84.93) | 29(39.73) | <0.0001 | 8.28 | 3.52–19.48 | <0.0001 |
≥140/90 mm Hg | 29 (39.73) | 40(54.79) | 11(15.07) | 44(60.27) | 1(ref) | ||||
LDL-c target | |||||||||
<100 mg/dl | 38(52.05) | 38(52.05) | 1.000 | 40(54.79) | 28(38.36) | 0.068 | 2.22 | 1.06–4.68 | 0.035 |
≥ 100 mg/dl) | 35(47.95) | 35(47.95) | 33(45.21) | 45(61.64) | 1(ref) | ||||
Composite Score 1 | |||||||||
Favourable | 5(6.85) | 4(5.48) | 0.712 | 7(9.59) | 1(1.37) | 0.013 | 10.20 | 0.69–174.19 | 0.060 |
Unfavourable | 68(93.15) | 69(94.52) | 66(90.41) | 72(98.63) | 1(ref) | ||||
Composite Score 2 | |||||||||
Favourable | 11(15.07) | 10(13.70) | 1.000 | 20(27.40) | 4(5.48) | 0.001 | 8.22 | 2.02–33.49 | 0.003 |
Unfavourable | 62(84.93) | 63(86.30) | 53(72.60) | 69(94.52) | 1(ref) | ||||
BMI | |||||||||
<23 Kg/m2 | 6(8.22) | 15(20.55) | 0.057 | 11(15.07) | 5(6.85) | 0.184 | 61.73 | 3.19–1193 | 0.006 |
≥23 Kg/m2 | 67(91.78) | 58(79.45) | 62(84.93) | 68(93.15) | 1(ref) | ||||